Pharmafile Logo
Pharmafocus logo
Advanced Search

J&J

Showing 15 posts of 227 posts found.

shutterstock_159488225

Renewed BARDA backing boosts J&J’s COVID-19 vaccine funding by $1bn

November 17, 2020
Manufacturing and Production, Research and Development BARDA, COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has said that it is injecting around $1 billion of funding into its research efforts to develop …

News

J&J launches second global COVID-19 vaccine trial, evaluating two-dose regimen

November 16, 2020
Research and Development, Sales and Marketing COVID-19, J&J, JJ, Janssen, Vaccine

Johnson & Johnson has kicked off a second global Phase 3 trial to assess the safety and efficacy of its …

News

J&J’s appeal shot down over $2.12m payment due to allegedly carcinogenic talc products

November 4, 2020
Research and Development, Sales and Marketing J&J, JJ, baby powder, ovarian cancer, talc

Johnson & Johnson has suffered a legal defeat in its ongoing dispute with consumers over damages relating to use of …

News
shutterstock_512649

Johnson & Johnson to contribute a further $1 billion to US opioid settlement

October 14, 2020
Research and Development, Sales and Marketing J&J, JJ, opioid crisis, opioids, pharma

Johnson & Johnson will pay another $1 billion to settle lawsuits alleging it fuelled the opioid crisis in the US. …

News

J&J halts COVID-19 vaccine study following unidentified participant illness

October 13, 2020
Manufacturing and Production, Research and Development COVID-19, J&J, JJ, Vaccine, pharma

Johnson & Johnson has announced its decision to slam the brakes on the development programme for its COVID-19 vaccine following …

News
782px-golden_hamster_front_1

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters

September 4, 2020
Medical Communications COVID-19, J&J, JJ

Johnson & Johnson’s vaccine candidate for COVID-19 has shown efficacy in a small group of Syrian golden hamsters.

News
shutterstock_244903099

Novavax and Janssen commit 90 million COVID-19 vaccine doses to UK Government with two new deals

August 14, 2020
Manufacturing and Production, Medical Communications, Sales and Marketing COVID-19, J&J, JJ, Novavax, UK, pharma

The UK Government has signed a new deal with Johnson & Johnson and Novavax to secure 90 million orders of …

News
j_and_j

US to pay Johnson and Johnson $1 billion for COVID-19 vaccine

August 6, 2020
Business Services COVID-19, J&J, JJ, Johnson and Johnson, coronavirus

The US will pay Johnson and Johnson more than $1 billion to create 100 million doses of COVID-19 vaccine. The …

News

J&J under fire from 170 nonprofits to halt baby powder sales worldwide because it contains asbestos

July 9, 2020
Sales and Marketing Cancer, J&J, JJ, pharma, talc

In the latest chapter in Johnson & Johnson’s talc-related woes, the company is being pressured by group of over 170 …

News
china-pharmaceutical-industry

Emergent forges five-year partnership to produce one billion doses of Janssen’s COVID-19 vaccine

July 7, 2020
Manufacturing and Production COVID-19, Emergent, J&J, JJ, Janssen, coronavirus

As many pharma firms move to secure upscaled manufacturing capacity for their potential COVID-19 vaccines, Johnson & Johnson’s Janssen has …

News
johnsonsss

Johnson & Johnson cuts price of anti-TB medicine in poorer countries

July 7, 2020
Manufacturing and Production J&J, JJ, TB

Johnson & Johnson have announced that it will cut the price of its tuberculosis drug Bedaquiline, sold under the brand …

News
shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020
Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …

News
26795063175_fe37f336f7_b

Jury orders Johnson & Johnson to pay $750 million in latest baby powder case

February 7, 2020
Medical Communications J&J, JJ, Johnson & Johnson, ovarian cancer, talc, talc powder

Johnson & Johnson have been ordered to pay by a jury $750 million to four plaintiffs over the company’s baby …

News

Johnson & Johnson CEO testifies for the first time in Baby Powder Cancer trial

January 28, 2020
Manufacturing and Production J&J, JJ, Johnson & Johnson, Talc Powder Cancer, baby powder, talc powder

Johnson & Johnson CEO Alex Gorsky faced questions around stock sales and his knowledge of asbestos in the company’s baby …

News
jj

J&J’s CAR-T candidate boasts 100% response rate in relapsed or refractory multiple myeloma

December 9, 2019
Research and Development, Sales and Marketing ASH 2019, CAR-T, J&J, JJ, Johnson & Johnson, pharma

Johnson & Johnson were present at the American Society of Hematology (ASH) Annual Meeting over the weekend to unveil new …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026